TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $191 | -89.3% | 22,857 | -68.0% | 0.02% | -91.0% |
| Q2 2023 | $1,777 | +253.3% | 71,518 | +114.1% | 0.18% | +256.0% |
| Q1 2023 | $503 | -67.8% | 33,411 | -74.7% | 0.05% | -74.2% |
| Q4 2022 | $1,560 | -99.3% | 131,893 | +234.2% | 0.19% | +525.8% |
| Q3 2022 | $234,000 | +21.9% | 39,466 | -12.8% | 0.03% | +6.9% |
| Q2 2022 | $192,000 | -68.1% | 45,281 | -28.3% | 0.03% | -64.2% |
| Q1 2022 | $601,000 | +194.6% | 63,184 | +488.1% | 0.08% | +211.5% |
| Q4 2021 | $204,000 | -39.1% | 10,744 | +66.8% | 0.03% | -52.7% |
| Q4 2020 | $335,000 | -2.3% | 6,442 | -89.5% | 0.06% | +19.6% |
| Q3 2019 | $343,000 | – | 61,115 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |